{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:22:22Z","timestamp":1794241342106,"version":"4.9.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010828","name":"Department of Education of Guizhou Province","doi-asserted-by":"publisher","award":["KY[2018]072"],"award-info":[{"award-number":["KY[2018]072"]}],"id":[{"id":"10.13039\/501100010828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","award":["2022YFS0434"],"award-info":[{"award-number":["2022YFS0434"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["ZK[2021]090"],"award-info":[{"award-number":["ZK[2021]090"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115274","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T19:22:58Z","timestamp":1691090578000},"page":"115274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies"],"prefix":"10.1016","volume":"165","author":[{"given":"Yuting","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsedien","family":"Nhamdriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115274_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism disrupting chemicals and metabolic disorders","volume":"68","author":"Heindel","year":"2017","journal-title":"Reprod. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115274_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1464-5491.2006.01925.x","article-title":"Incidence and trends of childhood Type 1 diabetes worldwide 1990\u20131999","volume":"23","author":"Group","year":"2006","journal-title":"Diabet. Med."},{"issue":"12","key":"10.1016\/j.biopha.2023.115274_bib3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-8587(14)70144-5","article-title":"Diabetes in China: a societal solution for a personal challenge","volume":"2","author":"Chan","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10085","key":"10.1016\/j.biopha.2023.115274_bib4","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","article-title":"Type 2 diabetes","volume":"389","author":"Chatterjee","year":"2017","journal-title":"lancet"},{"issue":"6","key":"10.1016\/j.biopha.2023.115274_bib5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.biopha.2023.115274_bib6","first-page":"2013","article-title":"Consensus for diagnosis and treatment of nonalcoholic fatty liver diseases and metabolic disorders","volume":"34","year":"2018","journal-title":"J. Clin. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta\u2010analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"9765","key":"10.1016\/j.biopha.2023.115274_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants","volume":"377","author":"Finucane","year":"2011","journal-title":"lancet"},{"key":"10.1016\/j.biopha.2023.115274_bib9","unstructured":"W.H. Organization, World Health Organization.(2021). Obesity and overweight. Retrieved from \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight\u3009."},{"key":"10.1016\/j.biopha.2023.115274_bib10","article-title":"Effects of Rosiglitazone combined with polyene phosphatidylcholine on liver function and lipid levels in patients with non-alcoholic steatohepatitis","volume":"4","author":"Zhang","year":"2019","journal-title":"J. Mod. Med. Health"},{"issue":"10","key":"10.1016\/j.biopha.2023.115274_bib11","first-page":"91","article-title":"Clinical efficacy and safety of Jiangzhi Ligan Decoction combined with acupuncture in the treatment of nonalcoholic fatty liver disease","volume":"36","author":"He","year":"2018","journal-title":"J. Sichuan Tradit. Chin."},{"issue":"6","key":"10.1016\/j.biopha.2023.115274_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/molecules21060807","article-title":"Natural products to counteract the epidemic of cardiovascular and metabolic disorders","volume":"21","author":"Waltenberger","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115274_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110984","article-title":"Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence","volume":"133","author":"Xu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115274_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6678662","article-title":"The therapeutic effects and mechanisms of quercetin on metabolic diseases: pharmacological data and clinical evidence","volume":"2021","author":"Yi","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2023.115274_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104632","article-title":"Magnoflorine: a review of its pharmacology, pharmacokinetics and toxicity","volume":"152","author":"Xu","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.115274_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100033","article-title":"The therapeutic effects and mechanisms of salidroside on cardiovascular and metabolic diseases: An updated review","volume":"18","author":"Zhao","year":"2021","journal-title":"Chem. Biodivers."},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib17","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/ijms24043323","article-title":"Therapeutic effect of curcumin on metabolic diseases: evidence from clinical studies","volume":"24","author":"Zeng","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13410-015-0437-6","article-title":"Impact of sub-gastrectomy on glucose regulation in gastric cancer patients with T2DM: a follow-up study","volume":"36","author":"Zhang","year":"2016","journal-title":"Int. J. Diabetes Dev. Ctries."},{"key":"10.1016\/j.biopha.2023.115274_bib19","first-page":"61","article-title":"Therapeutic efficacy of combined berberine and glipizide on type 2 diabetes","volume":"01","author":"Li","year":"2007","journal-title":"J. Clin. Res."},{"issue":"07","key":"10.1016\/j.biopha.2023.115274_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1055\/s-0044-101752","article-title":"Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial","volume":"68","author":"Panahi","year":"2018","journal-title":"Drug Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.115274_bib21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jcjd.2019.04.007","article-title":"Effectiveness of genistein supplementation on metabolic factors and antioxidant status in postmenopausal women with type 2 diabetes mellitus","volume":"43","author":"Braxas","year":"2019","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.biopha.2023.115274_bib22","unstructured":"H. Zang, The effect of silybin on insulin resistance in patients with type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease, Jilin University, 2021."},{"issue":"2013)","key":"10.1016\/j.biopha.2023.115274_bib23","article-title":"Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients","author":"Movahed","year":"2013","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib24","article-title":"Clinical study of puerarin on insulin resistance in patients with type 2 diabetes mellitus","volume":"17","author":"Wei","year":"2017","journal-title":"World Latest Med. Inf. (Electron. Version)"},{"key":"10.1016\/j.biopha.2023.115274_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clnesp.2019.10.015","article-title":"Impact of rutin and vitamin C combination on oxidative stress and glycemic control in patients with type 2 diabetes","volume":"35","author":"Ragheb","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3945\/jn.114.205674","article-title":"Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients","volume":"145","author":"Li","year":"2015","journal-title":"J. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2023.115274_bib27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ptr.6867","article-title":"Randomized double\u2010blind clinical trial examining the Ellagic acid effects on glycemic status, insulin resistance, antioxidant, and inflammatory factors in patients with type 2 diabetes","volume":"35","author":"Ghadimi","year":"2021","journal-title":"Phytother. Res."},{"issue":"10","key":"10.1016\/j.biopha.2023.115274_bib28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/nu9101104","article-title":"Role of purified anthocyanins in improving cardiometabolic risk factors in chinese men and women with prediabetes or early untreated diabetes-a randomized controlled trial","volume":"9","author":"Yang","year":"2017","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.biopha.2023.115274_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5923\/j.diabetes.20120103.01","article-title":"Quercetin dampens postprandial hyperglycemia in type 2 diabetic patients challenged with carbohydrates load","volume":"1","author":"Hussain","year":"2012","journal-title":"Int. J. Diabetes Res."},{"issue":"10","key":"10.1016\/j.biopha.2023.115274_bib30","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/ptr.5881","article-title":"Hesperidin supplementation alleviates oxidative DNA damage and lipid peroxidation in type 2 diabetes: a randomized double\u2010blind placebo\u2010controlled clinical trial","volume":"31","author":"Homayouni","year":"2017","journal-title":"Phytother. Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9149(02)02553-5","article-title":"Insulin resistance as the core defect in type 2 diabetes mellitus","volume":"90","author":"Goldstein","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2023.115274_bib32","unstructured":"W. Wang, Effect of Berberine on Blood Glucose, Blood Lipid and Serum Leptin of Primary Type 2 Diabetes Mellitus Patients, Shanxi Medical University, 2008."},{"issue":"2","key":"10.1016\/j.biopha.2023.115274_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jnutbio.2013.09.013","article-title":"Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial","volume":"25","author":"Chuengsamarn","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2023.115274_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1017\/S0007114511000316","article-title":"Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients","volume":"106","author":"Brasny\u00f3","year":"2011","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pcd.2014.03.007","article-title":"Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus","volume":"9","author":"Zhu","year":"2015","journal-title":"Prim. Care Diabetes"},{"issue":"10","key":"10.1016\/j.biopha.2023.115274_bib36","first-page":"937","article-title":"Guidelines for Prevention and Treatment of dyslipidemia in Adults in China (Revised Edition 2016)","volume":"31","author":"Zhu","year":"2016","journal-title":"Chin. Circ. J."},{"issue":"8","key":"10.1016\/j.biopha.2023.115274_bib37","first-page":"246","article-title":"Resveratrol supplementation in patients with type 2 diabetes mellitus: a prospective, open label, randomized controlled trial","volume":"4","author":"Kumar","year":"2013","journal-title":"Int. Res. J. Pharm."},{"issue":"06","key":"10.1016\/j.biopha.2023.115274_bib38","first-page":"213","article-title":"Clinical effect of Silybin capsule combined with metformin in the treatment of newly diagnosed type 2 diabetes mellitus with nonalcoholic fatty liver","volume":"42","author":"Zhang","year":"2019","journal-title":"Heilongjiang Med. Pharm."},{"issue":"18","key":"10.1016\/j.biopha.2023.115274_bib39","first-page":"4885","article-title":"Clinical observation on the Berberine plus metformin in treatment of type 2 diabetes complicated by nonalcoholic fatty liver disease","volume":"39","author":"Cao","year":"2012","journal-title":"Mod. Prev. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib40","first-page":"0975","article-title":"LDL lowering properties of rutin in diabetic patients","volume":"1","author":"Sattanathan","year":"2019","journal-title":"Int. J. Pharma Bio Sci."},{"issue":"05","key":"10.1016\/j.biopha.2023.115274_bib41","first-page":"857","article-title":"Effects of resveratrol combined with periodontal nonoperative treatment on periodontal indexes, inflammatory factors and glucose and lipid metabolism in type 2 diabetic patients with chronic periodontitis","volume":"20","author":"Zhao","year":"2021","journal-title":"Chin. J. Public Health Eng."},{"key":"10.1016\/j.biopha.2023.115274_bib42","unstructured":"D. Li, Y. Zhang, Y. Liu, R. Sun, M. Xia, The effect of anthocyanin intervention on the improvement of blood lipid disorder, antioxidant capacity and insulin resistance in diabetic patients, The 13th National Nutrition Science Conference of Chinese Nutrition Society and the Global Chinese Nutrition Scientists Conference, Beijing China, 2017, pp. 429\u2013430."},{"key":"10.1016\/j.biopha.2023.115274_bib43","series-title":"Dietary sugar, salt and fat in human health","first-page":"305","article-title":"Associations of high blood sugar with oxidative stress and inflammation in patients with type 2 diabetes","author":"Wojcik","year":"2020"},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/dc12-0702","article-title":"Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.biopha.2023.115274_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ptr.6046","article-title":"Blood pressure lowering and anti\u2010inflammatory effects of hesperidin in type 2 diabetes; a randomized double\u2010blind controlled clinical trial","volume":"32","author":"Homayouni","year":"2018","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00126839-200809040-00004","article-title":"Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus","volume":"9","author":"Usharani","year":"2008","journal-title":"Drugs R. D."},{"key":"10.1016\/j.biopha.2023.115274_bib47","first-page":"1418","article-title":"Effect of berberine combined with metformin on serum inflammatory factors and islet function in type 2 diabetes mellitus","volume":"37","author":"Dong","year":"2017","journal-title":"J. Clin. Pathol. Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.115274_bib48","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/ptr.7124","article-title":"Inflammatory markers response to crocin supplementation in patients with type 2 diabetes mellitus: a randomized controlled trial","volume":"35","author":"Behrouz","year":"2021","journal-title":"Phytother. Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib49","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/ptr.6328","article-title":"The effects of curcumin supplementation on high\u2010sensitivity C\u2010reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: a randomized, double\u2010blind, placebo\u2010controlled trial","volume":"33","author":"Adibian","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2023.115274_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives","author":"Bhatti","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2023.115274_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5953685","article-title":"Circulating oxidative stress biomarkers in clinical studies on type 2 diabetes and its complications","volume":"2019","author":"Bigagli","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10787-016-0301-4","article-title":"Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial","volume":"25","author":"Panahi","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2023.115274_bib53","unstructured":"Z. Mazloom, Z.S.M. Abdollahzadeh, M.H. Dabbaghmanesh, A. Rezaianzadeh, The effect of quercetin supplementation on oxidative stress, glycemic control, lipid profile and insulin resistance in type 2 diabetes: a randomized clinical trial, (2014)."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/2230-8210.163172","article-title":"Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes","volume":"19","author":"Sanyal","year":"2015","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2023.115274_bib55","doi-asserted-by":"crossref","DOI":"10.3945\/ajcn.115.118695","article-title":"Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level","volume":"103","author":"Sookoian","year":"2016","journal-title":"Am. J. Clin. Nutr.: Off. J. Am. Soc. Clin. Nutr."},{"issue":"06","key":"10.1016\/j.biopha.2023.115274_bib56","first-page":"633","article-title":"Observation of the therapeutic effect of metformin combined with berberine hydrochloride on non-alcoholic fatty liver","volume":"24","author":"Ren","year":"2015","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.biopha.2023.115274_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jnutbio.2019.03.006","article-title":"Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Lee","year":"2019","journal-title":"J. Nutr. Biochem."},{"issue":"9","key":"10.1016\/j.biopha.2023.115274_bib58","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ptr.5659","article-title":"Treatment of non\u2010alcoholic fatty liver disease with curcumin: a randomized placebo\u2010controlled trial","volume":"30","author":"Rahmani","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2023.115274_bib59","article-title":"Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease","author":"Mirhafez","year":"2019","journal-title":"Int. J. Vitam. Nutr. Res."},{"issue":"04","key":"10.1016\/j.biopha.2023.115274_bib60","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0043-100019","article-title":"Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"67","author":"Panahi","year":"2017","journal-title":"Drug Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41430-020-0679-3","article-title":"The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial","volume":"75","author":"Yari","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.biopha.2023.115274_bib62","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1111\/j.1572-0241.2001.04129.x","article-title":"Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study","volume":"96","author":"Abdelmalek","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115274_bib63","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1039\/C9FO01677E","article-title":"Regulation effects of rosemary (Rosmarinus officinalis Linn.) on hepatic lipid metabolism in OA induced NAFLD rats","volume":"10","author":"Wang","year":"2019","journal-title":"Food Funct."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib64","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.biopha.2023.115274_bib65","doi-asserted-by":"crossref","DOI":"10.15403\/jgld-179","article-title":"Effect of phytosomal curcumin on circulating levels of adiponectin and leptin in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial","volume":"28","author":"Mirhafez","year":"2019","journal-title":"J. Gastrointest. Liver Dis."},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib66","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.clnu.2017.05.028","article-title":"Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: a randomized, controlled trial","volume":"37","author":"Amanat","year":"2018","journal-title":"Clin. Nutr."},{"issue":"8","key":"10.1016\/j.biopha.2023.115274_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of berberine in patients with non-alcoholic fatty liver disease","volume":"10","author":"Yan","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000282083","article-title":"The role of cytokines in non-alcoholic fatty liver disease","volume":"28","author":"Tilg","year":"2010","journal-title":"Dig. Dis."},{"issue":"09","key":"10.1016\/j.biopha.2023.115274_bib69","first-page":"1048","article-title":"Clinical observation of berberine combined with probiotics in the treatment of non-alcoholic fatty liver, Chinese","volume":"31","author":"Wang","year":"2016","journal-title":"J. Control Endem. Dis."},{"issue":"05","key":"10.1016\/j.biopha.2023.115274_bib70","first-page":"496","article-title":"Therapeutic effect of metformin combined with berberine hydrochloride on nonalcoholic fatty liver and its effect on the levels of IL-17 and TGF-\u03b2","volume":"26","author":"Han","year":"2017","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.biopha.2023.115274_bib71","article-title":"Effect of berberine combined with insulin sensitizer on nonalcoholic fatty liver disease and its influence on oxidative stress","author":"Hui","year":"2017","journal-title":"Chin. J. Integr. Tradit. West. Med. Dig."},{"key":"10.1016\/j.biopha.2023.115274_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102322","article-title":"Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"49","author":"Saberi-Karimian","year":"2020","journal-title":"Complement. Ther. Med."},{"issue":"9","key":"10.1016\/j.biopha.2023.115274_bib73","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.dld.2020.09.021","article-title":"Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD","volume":"53","author":"Mosca","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.biopha.2023.115274_bib74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2036.2005.02601.x","article-title":"role of oxidative stress in the progression of non\u2010alcoholic steatosis","volume":"22","author":"Albano","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0168-8278(02)00073-9","article-title":"In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases","volume":"37","author":"Seki","year":"2002","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00365520701559003","article-title":"Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet","volume":"43","author":"Machado","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.115274_bib77","unstructured":"Expert consensus on obesity prevention and treatment in China, Journal of Xi'an Jiaotong University\uff08Medical Sciences\uff09 43(04) (2022) 619\u2013631."},{"issue":"3","key":"10.1016\/j.biopha.2023.115274_bib78","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.clnu.2015.05.003","article-title":"Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial","volume":"35","author":"Chen","year":"2016","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2023.115274_bib79","first-page":"67","article-title":"The nanocurcumin reduces appetite in obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial","volume":"5","author":"Jazayeri-Tehrani","year":"2018","journal-title":"Nanomed. J."},{"issue":"01","key":"10.1016\/j.biopha.2023.115274_bib80","first-page":"54","article-title":"Effects of berberine hydrochloride on body weight of obese prediabetic patients and the outcome after treatment","volume":"25","author":"Chen","year":"2017","journal-title":"Chin. J. Prev. Control Chronic Dis."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib81","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib82","doi-asserted-by":"crossref","first-page":"389S","DOI":"10.1080\/07315724.2007.10719627","article-title":"The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study","volume":"26","author":"Boschmann","year":"2007","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.biopha.2023.115274_bib83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nutres.2018.02.002","article-title":"Acute administration of capsaicin increases resting energy expenditure in young obese subjects without affecting energy intake, appetite, and circulating levels of orexigenic\/anorexigenic peptides","volume":"52","author":"Rigamonti","year":"2018","journal-title":"Nutr. Res."},{"key":"10.1016\/j.biopha.2023.115274_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111908","article-title":"Seed peptide lunasin ameliorates obesity-induced inflammation and regulates immune responses in C57BL\/6J mice fed high-fat diet","volume":"147","author":"Hsieh","year":"2021","journal-title":"Food Chem. Toxicol."},{"issue":"2012)","key":"10.1016\/j.biopha.2023.115274_bib85","article-title":"Inhibitory effects of chung hun wha dam tang (CHWDT) on high-fat diet-induced obesity via AMP-activated protein kinase activation","author":"Uddin","year":"2012","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-019-0331-1","article-title":"Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial","volume":"16","author":"Jazayeri-Tehrani","year":"2019","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.biopha.2023.115274_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/898361","article-title":"Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial","volume":"2014","author":"Ganjali","year":"2014","journal-title":"Sci. World J."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib88","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","article-title":"Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans","volume":"14","author":"Timmers","year":"2011","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.biopha.2023.115274_bib89","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.phymed.2012.05.009","article-title":"Lipid-lowering effect of berberine in human subjects and rats","volume":"19","author":"Hu","year":"2012","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.biopha.2023.115274_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14852","article-title":"Hosseinzadeh\u2010Attar, Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight\/obese patients with NAFLD? A randomised, double\u2010blind, placebo\u2010controlled, clinical trial","volume":"75","author":"Namkhah","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib91","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.atherosclerosis.2008.11.006","article-title":"Circulating oxidized LDL levels, current smoking and obesity in postmenopausal women","volume":"205","author":"Kassi","year":"2009","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.biopha.2023.115274_bib92","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1017\/S0007114509359127","article-title":"Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study","volume":"102","author":"Egert","year":"2009","journal-title":"Br. J. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2023.115274_bib93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1139\/apnm-2013-0133","article-title":"Effects of curcumin on brain-derived neurotrophic factor levels and oxidative damage in obesity and diabetes","volume":"39","author":"Franco-Robles","year":"2014","journal-title":"Appl. Physiol., Nutr., Metab."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib94","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/oby.22175","article-title":"Gut microbes and health: a focus on the mechanisms linking microbes, obesity, and related disorders","volume":"26","author":"Rastelli","year":"2018","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib95","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/17474124.2019.1543023","article-title":"Obesity, diabetes, and the gut microbiome: an updated review","volume":"13","author":"Singer-Englar","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.115274_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112839","article-title":"Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus","volume":"149","author":"Du","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115274_bib97","first-page":"734","article-title":"The interplay between herbal medicines and gut microbiota in metabolic diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000948","article-title":"Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects","volume":"8","author":"Guevara-Cruz","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"12","key":"10.1016\/j.biopha.2023.115274_bib99","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/1753-0407.13337","article-title":"Yogliptin monotherapy in type 2 diabetes: a 12\u2013week randomized, double\u2010blind, placebo\u2010controlled phase II study","volume":"14","author":"Wang","year":"2022","journal-title":"J. Diabetes"},{"issue":"Supplement_1","key":"10.1016\/j.biopha.2023.115274_bib100","doi-asserted-by":"crossref","DOI":"10.2337\/db23-55-OR","article-title":"55-OR: HSK7653, a novel ultralong-acting DPP-4 inhibitor, as monotherapy in patients with type 2 diabetes-a randomized, double-blind, placebo-controlled phase III trial","volume":"72","author":"Ji","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.115274_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)01053-X","article-title":"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA","author":"Rosenstock","year":"2023","journal-title":"Lancet"},{"issue":"10215","key":"10.1016\/j.biopha.2023.115274_bib102","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115274_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2019.12.129","article-title":"Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results","volume":"52","author":"Lucas","year":"2020","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib104","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2020.08.004","article-title":"Efficacy and safety of aldafermin, an engineered FGF19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis","volume":"160","author":"Harrison","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2023.115274_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101088","article-title":"IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: a randomised, placebo-controlled, multiple ascending dose phase 1b study","volume":"39","author":"Ji","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"10317","key":"10.1016\/j.biopha.2023.115274_bib106","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","article-title":"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","volume":"398","author":"Lau","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2023.115274_bib107","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00011-021-01438-1","article-title":"Potential of anthocyanin as an anti-inflammatory agent: a human clinical trial on type 2 diabetic, diabetic at-risk and healthy adults","volume":"70","author":"Nikbakht","year":"2021","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib108","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib109","first-page":"567","article-title":"The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial","volume":"6","author":"Rahimi","year":"2016","journal-title":"Avicenna J. Phytomed."},{"key":"10.1016\/j.biopha.2023.115274_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctim.2017.05.006","article-title":"Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial","volume":"33","author":"Panahi","year":"2017","journal-title":"Complement. Ther. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib111","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1574884713666180104095641","article-title":"Curcuminoids plus piperine modulate adipokines in type 2 diabetes mellitus","volume":"12","author":"Panahi","year":"2017","journal-title":"Curr. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115274_bib112","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ptr.5201","article-title":"Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type\u20102 diabetes mellitus","volume":"28","author":"Neerati","year":"2014","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib113","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00592-017-1098-3","article-title":"The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial","volume":"55","author":"Seyyedebrahimi","year":"2018","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.biopha.2023.115274_bib114","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nutres.2018.03.015","article-title":"Resveratrol supplementation decreases blood glucose without changing the circulating CD14+ CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study","volume":"54","author":"Khodabandehloo","year":"2018","journal-title":"Nutr. Res."},{"issue":"8","key":"10.1016\/j.biopha.2023.115274_bib115","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/ptr.6655","article-title":"The effect of resveratrol supplementation on serum levels of asymmetric de\u2010methyl\u2010arginine and paraoxonase 1 activity in patients with type 2 diabetes: a randomized, double\u2010blind controlled trial","volume":"34","author":"Tabatabaie","year":"2020","journal-title":"Phytother. Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.115274_bib116","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nutres.2012.06.003","article-title":"Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus","volume":"32","author":"Bhatt","year":"2012","journal-title":"Nutr. Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib117","article-title":"An observational study of the antidiabetic activity of berberine in newly diagnosed type 2 diabetes mellitus patients","volume":"6","author":"Dange","year":"2016","journal-title":"J. Pharm. Biomed. Sci."},{"key":"10.1016\/j.biopha.2023.115274_bib118","doi-asserted-by":"crossref","DOI":"10.4103\/jrms.JRMS_1078_17","article-title":"Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients","volume":"23","author":"Memon","year":"2018","journal-title":"J. Res. Med. Sci.: Off. J. Isfahan Univ. Med. Sci."},{"key":"10.1016\/j.biopha.2023.115274_bib119","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clnesp.2020.09.029","article-title":"Curcumin administration and the effects on psychological status and markers of inflammation and oxidative damage in patients with type 2 diabetes and coronary heart disease","volume":"40","author":"Shafabakhsh","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ptr.5737","article-title":"The impact of resveratrol supplementation on blood glucose, insulin, insulin resistance, triglyceride, and periodontal markers in type 2 diabetic patients with chronic periodontitis","volume":"31","author":"Zare Javid","year":"2017","journal-title":"Phytother. Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.115274_bib121","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1210\/jc.2007-2404","article-title":"Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine","volume":"93","author":"Zhang","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2023.115274_bib122","first-page":"290","article-title":"The effects of nano-curcumin on metabolic status in patients with diabetes on hemodialysis, a randomized, double blind, placebo-controlled trial","volume":"14","author":"Shafabakhsh","year":"2020","journal-title":"Iran. J. Kidney Dis."},{"issue":"11","key":"10.1016\/j.biopha.2023.115274_bib123","first-page":"902","article-title":"Curcuminoids target decreasing serum adipocyte-fatty acid binding protein levels in their glucose-lowering effect in patients with type 2 diabetes","volume":"27","author":"Na","year":"2014","journal-title":"Biomed. Environ. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2023.115274_bib124","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/mnfr.201200131","article-title":"Curcuminoids exert glucose\u2010lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double\u2010blind, placebo\u2010controlled trial","volume":"57","author":"Na","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115274_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-019-0437-7","article-title":"The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial","volume":"11","author":"Hodaei","year":"2019","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.biopha.2023.115274_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8208237","article-title":"Effects of highly absorbable curcumin in patients with impaired glucose tolerance and non-insulin-dependent diabetes mellitus","volume":"2019","author":"Funamoto","year":"2019","journal-title":"J. Diabetes Res."},{"issue":"68","key":"10.1016\/j.biopha.2023.115274_bib127","article-title":"Observation of clinical effect of metformin combined with berberine hydrochloride in the treatment of non-alcoholic fatty liver","volume":"4","author":"Lin","year":"2017","journal-title":"Electron. J. Clin. Med. Lit."},{"issue":"09","key":"10.1016\/j.biopha.2023.115274_bib128","first-page":"1032","article-title":"Observation of the therapeutic effect of metformin combined with berberine hydrochloride on non-alcoholic fatty liver","volume":"25","author":"Fu","year":"2013","journal-title":"Mod. Prac. Med."},{"issue":"5","key":"10.1016\/j.biopha.2023.115274_bib129","first-page":"423","article-title":"Effects of berberine on insulin resistance and serumadiponectin of nonalcoholic fatty liver patients","volume":"25","author":"Bai","year":"2011","journal-title":"Pr. Geriatr."},{"key":"10.1016\/j.biopha.2023.115274_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102447","article-title":"A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled, clinical trial","volume":"51","author":"Hariri","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.biopha.2023.115274_bib131","series-title":"Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health","first-page":"25","article-title":"The effect of curcumin phytosome on the treatment of patients with non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled trial","author":"Mirhafez","year":"2021"},{"issue":"9","key":"10.1016\/j.biopha.2023.115274_bib132","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1002\/jcb.28877","article-title":"Curcuminoids plus piperine improve nonalcoholic fatty liver disease: a clinical trial","volume":"120","author":"Panahi","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.biopha.2023.115274_bib133","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10286020.2018.1505873","article-title":"Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study","volume":"21","author":"Panahi","year":"2019","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"6","key":"10.1016\/j.biopha.2023.115274_bib134","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/hep.23239","article-title":"Betaine for nonalcoholic fatty liver disease: results of a randomized placebo\u2010controlled trial","volume":"50","author":"Abdelmalek","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2023.115274_bib135","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/ijo.2013.155","article-title":"The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men","volume":"38","author":"Konings","year":"2014","journal-title":"Int. J. Obes."},{"issue":"2","key":"10.1016\/j.biopha.2023.115274_bib136","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00394-019-01916-7","article-title":"Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial","volume":"59","author":"Cicero","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.biopha.2023.115274_bib137","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jff.2017.02.031","article-title":"Anthocyanin supplementation in alleviating thrombogenesis in overweight and obese population: a randomized, double-blind, placebo-controlled study","volume":"32","author":"Thompson","year":"2017","journal-title":"J. Funct. Foods"},{"issue":"8","key":"10.1016\/j.biopha.2023.115274_bib138","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/ptr.6370","article-title":"Effects of curcumin supplementation on markers of inflammation and oxidative stress among healthy overweight and obese girl adolescents: a randomized placebo\u2010controlled clinical trial","volume":"33","author":"Saraf\u2010Bank","year":"2019","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.biopha.2023.115274_bib139","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1002\/ptr.7136","article-title":"The effect of curcumin and zinc co\u2010supplementation on glycemic parameters in overweight or obese prediabetic subjects: a phase 2 randomized, placebo\u2010controlled trial with a multi\u2010arm, parallel\u2010group design","volume":"35","author":"Karandish","year":"2021","journal-title":"Phytother. Res."},{"issue":"21","key":"10.1016\/j.biopha.2023.115274_bib140","first-page":"4195","article-title":"Potential role of bioavailable curcumin in weight loss and omental adipose tissue decrease: preliminary data of a randomized, controlled trial in overweight people with metabolic syndrome. Preliminary study","volume":"19","author":"Di Pierro","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115274_bib141","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000002323","article-title":"Effects of naringenin supplementation on cardiovascular risk factors in overweight\/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial","volume":"34","author":"Naeini","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115274_bib142","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/ptr.6166","article-title":"The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome","volume":"32","author":"Khorshidi","year":"2018","journal-title":"Phytother. Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222301065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222301065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:09:45Z","timestamp":1777878585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222301065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":142,"alternative-id":["S075333222301065X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115274","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115274"}}